Increased Risk for Non-Hodgkin Lymphoma in Individuals With Celiac Disease and a Potential Familial Association

Gastroenterology

Volumn 136, Issue 1, 2009, Pages 91-98

  Gao, Ying ^a   Kristinsson, Sigurdur Y ^b   Goldin, Lynn R ^a   Björkholm, Magnus ^b   Caporaso, Neil E ^a   Landgren, Ola ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ANAMNESIS; ARTICLE; CELIAC DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; HODGKIN DISEASE; HOSPITAL DISCHARGE; HUMAN; LYMPHATIC LEUKEMIA; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RISK FACTOR; CHRONIC LYMPHATIC LEUKEMIA; GENETICS; MIDDLE AGED; RISK;

ADULT; AGED; CELIAC DISEASE; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; RISK;

EID: 59849112637     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2008.09.031     Document Type: Article

References (46)

1. Ciclitira P.J., Johnson M.W., Dewar D.H., et al. The pathogenesis of coeliac disease. Mol Aspects Med 26 (2005) 421-458
2. Green P.H., and Cellier C. Celiac disease. N Engl J Med 357 (2007) 1731-1743
3. Green P.H., Rostami K., and Marsh M.N. Diagnosis of coeliac disease. Best Pract Res Clin Gastroenterol 19 (2005) 389-400
4. Fasano A. Clinical presentation of celiac disease in the pediatric population. Gastroenterology 128 4 Suppl 1 (2005) S68-S73
5. Fasano A., Berti I., Gerarduzzi T., et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med 163 (2003) 286-292
6. Fairly N., and Mackie F. The clinical and biochemical syndrome in lymphoma and allied diseases involving the mesenteric lymph glands. BMJ 1 (1937) 375-380
7. Askling J., Linet M., Gridley G., et al. Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis. Gastroenterology 123 (2002) 1428-1435
8. Goldacre M.J., Wotton C.J., Yeates D., et al. Cancer in patients with ulcerative colitis, Crohn's disease and coeliac disease: record linkage study. Eur J Gastroenterol Hepatol 20 (2008) 297-304
9. Fasano A., and Catassi C. Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. Gastroenterology 120 (2001) 636-651
10. Leonard J.N., Tucker W.F., Fry J.S., et al. Increased incidence of malignancy in dermatitis herpetiformis. Br Med J (Clin Res Ed) 286 (1983) 16-18
11. Anderson L.A., McMillan S.A., Watson R.G., et al. Malignancy and mortality in a population-based cohort of patients with coeliac disease or "gluten sensitivity". World J Gastroenterol 13 (2007) 146-151
12. Silano M., Volta U., Mecchia A.M., et al. Delayed diagnosis of coeliac disease increases cancer risk. BMC Gastroenterol 7 (2007) 8
13. Smedby K.E., Hjalgrim H., Askling J., et al. Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype. J Natl Cancer Inst 98 (2006) 51-60
14. Mearin M.L., Catassi C., Brousse N., et al. European multi-centre study on coeliac disease and non-Hodgkin lymphoma. Eur J Gastroenterol Hepatol 18 (2006) 187-194
15. Viljamaa M., Kaukinen K., Pukkala E., et al. Malignancies and mortality in patients with coeliac disease and dermatitis herpetiformis: 30-year population-based study. Dig Liver Dis 38 (2006) 374-380
16. Smedby K.E., Akerman M., Hildebrand H., et al. Malignant lymphomas in coeliac disease: evidence of increased risks for lymphoma types other than enteropathy-type T cell lymphoma. Gut 54 (2005) 54-59
17. Card T.R., West J., and Holmes G.K. Risk of malignancy in diagnosed coeliac disease: a 24-year prospective, population-based, cohort study. Aliment Pharmacol Ther 20 (2004) 769-775
18. West J., Logan R.F., and Smith C.J. Malignancy and mortality in people with coeliac disease: population based cohort study. BMJ 329 (2004) 716-719
19. Farre C., Domingo-Domenech E., Font R., et al. Celiac disease and lymphoma risk: a multicentric case--control study in Spain. Dig Dis Sci 49 (2004) 408-412
20. Green P.H., Fleischauer A.T., Bhagat G., et al. Risk of malignancy in patients with celiac disease. Am J Med 115 (2003) 191-195
21. Peters U., Askling J., Gridley G., et al. Causes of death in patients with celiac disease in a population-based Swedish cohort. Arch Intern Med 163 (2003) 1566-1572
22. Howdle P.D., Jalal P.K., Holmes G.K., et al. Primary small-bowel malignancy in the UK and its association with coeliac disease. QJM 96 (2003) 345-353
23. Catassi C., Fabiani E., Corrao G., et al. Risk of non-Hodgkin lymphoma in celiac disease. JAMA 287 (2002) 1413-1419
24. Green P.H.R., Stavropoulos S.N., Panagi S.G., et al. Characteristics of adult celiac disease in the USA: results of a national survey. Am J Gastroenterol 96 (2001) 126-131
25. Cottone M., Termini A., Oliva L., et al. Mortality and causes of death in celiac disease in a Mediterranean area. Dig Dis Sci 44 (1999) 2538-2541
26. Catassi C., Fabiani E., Ratsch I.M., et al. The coeliac iceberg in Italy. A multicentre antigliadin antibodies screening for coeliac disease in school-age subjects. Acta Paediatr Suppl 412 (1996) 29-35
27. Bonamico M., Ferri M., Mariani P., et al. Serologic and genetic markers of celiac disease: a sequential study in the screening of first degree relatives. J Pediatr Gastroenterol Nutr 42 (2006) 150-154
28. Rubio-Tapia A., Van Dyke C.T., Lahr B.D., et al. Predictors of family risk for celiac disease: a population-based study. Clin Gastroenterol Hepatol 6 (2008) 983-987
29. The National Board of Health and Welfare. Cancer Incidence in Sweden 2001 (2003), Center for Epidemiology, Stockholm
30. Turesson I., Linet M.S., Bjorkholm M., et al. Ascertainment and diagnostic accuracy for hematopoietic lymphoproliferative malignancies in Sweden 1964-2003. Int J Cancer 121 (2007) 2260-2266
31. Skarle A. Population Statistics (2001), Statistics Sweden, Stockholm (Sweden)
32. The National Board of Health and Welfare. Cancer Incidence in Sweden 2003 (2004), Center for Epidemiology, Stockholm
33. Landgren O., Engels E.A., Caporaso N.E., et al. Patterns of autoimmunity and subsequent chronic lymphocytic leukemia in Nordic countries. Blood 108 (2006) 292-296
34. Mellemkjaer L., Pfeiffer R.M., Engels E.A., et al. Autoimmune disease in individuals and close family members and susceptibility to non-Hodgkin's lymphoma. Arthritis Rheum 58 (2008) 657-666
35. Landgren O., Engels E.A., Pfeiffer R.M., et al. Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in Scandinavia. J Natl Cancer Inst 98 (2006) 1321-1330
36. National Institutes of Health Consensus Development Conference Statement on Celiac Disease, June 28-30, 2004. Gastroenterology 128 4 Suppl 1 (2005) S1-S9
37. Hall R.P. Dietary management of dermatitis herpetiformis. Arch Dermatol 123 (1987) 1378a-1380a
38. Janatuinen E.K., Kemppainen T.A., Julkunen R.J., et al. No harm from five year ingestion of oats in coeliac disease. Gut 50 (2002) 332-335
39. Kumar P.J., and Farthing M.G. Oats and celiac disease. N Engl J Med 333 (1995) 1075-1076
40. Hogberg L., Grodzinsky E., and Stenhammar L. Better dietary compliance in patients with coeliac disease diagnosed in early childhood. Scand J Gastroenterol 38 (2003) 751-754
41. Lee S.K., Lo W., Memeo L., Rotterdam H., and Green P.H. Duodenal histology in patients with celiac disease after treatment with a gluten-free diet. Gastrointest Endosc 57 (2003) 187-191
42. Matysiak-Budnik T., Malamut G., de Serre N.P., et al. Long-term follow-up of 61 coeliac patients diagnosed in childhood: evolution toward latency is possible on a normal diet. Gut 56 (2007) 1379-1386
43. Mikkelsen A., Borres M., Kristiansson B., et al. Different policy on gluten-free food in child day care centers. Unified national guidelines are needed. Lakartidningen 95 (1998) 1820-1822 1824
44. Louka A.S., and Sollid L.M. HLA in coeliac disease: unravelling the complex genetics of a complex disorder. Tissue Antigens 61 (2003) 105-117
45. Monsuur A.J., and Wijmenga C. Understanding the molecular basis of celiac disease: what genetic studies reveal. Ann Med 38 (2006) 578-591
46. Olen O., Montgomery S.M., Elinder G., et al. Increased risk of immune thrombocytopenic purpura among inpatients with coeliac disease. Scand J Gastroenterol 43 (2008) 416-422